Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 302
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 1,751–1,800 of 1,926 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002951	Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer	completed	Phase 2	53	University of ChicagoOTHER	1	Sep 5, 2013	clinicaltrials
NCT00003192	Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus	completed	Phase 2	15	University of ChicagoOTHER	1	Sep 5, 2013	clinicaltrials
NCT01930630